Introduction to Cognitive Testing

Regulatory guidance in both Europe and the U.S. has mandated the use of cognitive testing in the development of drugs for a number of neurological and psychiatric disorders. A number of companies have also sought to incorporate cognitive testing as a means of testing drug safety and efficacy in exploratory studies. This approach has been especially popular in early phase II studies in which evidence of efficacy has now routinely been observed in studies of both modest size and length. Greater demand has led to a marked increase in the number of cognitive testing suppliers, who now offer sponsors a wide variety of tests and methods of assessment. This course has been designed to assist potential purchasers of cognitive testing services with the issues and requirements attached to the use of cognitive services with the issues and requirements attached to the use of cognitive testing in clinical drug trials.